Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Follicular NHL with Residual Disease Post-HSCT
NCT01388959Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 1998
- Primary completion
- Apr 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in follicular lymphoma (FL), sponsored by Roche. Started Nov 1998; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01388959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01388959.